India recorded 14,313 new coronavirus infections taking the total tally of COVID-19 cases to 3,39,85,920, while the active cases declined to 2,14,900, the lowest in 212 days, according to the Union Health Ministry data updated on Tuesday.
The number of deaths climbed to 4,50,963 with 181 fresh deaths, according to the data updated at 8 am.
The active cases comprise 0.63 per cent of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.04 per cent, the highest since March 2020, the ministry said.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
India crossed the grim milestone of two crore on May 4 and three crore on June 23.
Here are Highlights on Coronavirus Cases In India :
G20 Trade Ministers Vow To Work Towards Fairer COVID-19 Vaccine DistributionIndia's COVID-19 vaccination coverage crosses the 96 crore mark today. More than 46 lakh (46,23,892) doses have been administered till 7 pm today: Government of India pic.twitter.com/rsS8ighpu1
- ANI (@ANI) October 12, 2021
Gujarat reported 22 new COVID-19 cases on Tuesday, taking its case tally to 8,26,184, while the death toll remained unchanged at 10,086, an official said.
The discharge of 19 people during the day increased the recovery count to 8,15,909, leaving the state with 189 patients, five of whom are in critical condition, he said.
Delhi reported 34 new COVID-19 cases in the last 24 hours.
According to the health bulletin, the total number of COVID-19 cases in the national capital has gone up to 14,39,252 of which 14,13,798 have recovered. There are 365 active cases of COVID-19 in the city.
COVID-19 | Karnataka reports 332 new cases, 11 deaths and 515 recoveries today. Active cases 9712 and total positive cases 29,81,732 pic.twitter.com/NfHGo96zeS
- ANI (@ANI) October 12, 2021
Patna | Bihar government has set up COVID19 vaccination camps at Durga Puja Pandals
- ANI (@ANI) October 12, 2021
These vaccination camps have been set up to encourage people to get vaccinated. It is very important to keep COVID19 at bay: State Health Minister Mangal Pandey pic.twitter.com/TPXkXxWQ2S
COVID19 | Kerala reports 7,823 positive cases 12,490 recoveries and 106 deaths today. Active cases 96,646 pic.twitter.com/NLWkKTaheB
- ANI (@ANI) October 12, 2021
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
Shares of Everest Organics jumped as much as 11.6 per cent after the news came in, and were last up 9.9 per cent at Rs 330 in a weak Mumbai market. The Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug.
Merck has separately entered into voluntary licensing agreements with at least eight Indian generic drugmakers for molnupiravir, with an aim to turn the country into a manufacturing hub for the drug.
A British parliamentary report published Tuesday said that the government's delay in locking down society when Covid-19 hit last year had cost lives and was "one of the most important public health failures" in the country's history.
In a damning assessment, a cross-party group of MPs found that official pandemic planning was too focused on influenza and had failed to learn the lessons from prior outbreaks of SARS, MERS and Ebola.
The 151-page study, published by two parliamentary watchdog committees after months of hearings, comes ahead of an independent public inquiry into the government's coronavirus handling due to begin next year.
